8-K: CIMG Inc. Faces Imminent Nasdaq Delisting Over Unfiled Reports and Equity Deficiency

CIMG Inc. has received a delist determination letter from Nasdaq for failing to file its annual and quarterly reports and not meeting the minimum stockholders' equity requirement, with trading suspension set for July 9, 2025, unless an appeal is filed.

Summary

• CIMG Inc. received a delist determination letter from Nasdaq on June 27, 2025.
• The delisting is primarily due to the company's failure to file its Form 10-K for the fiscal year ended September 30, 2024, and Forms 10-Q for the periods ended December 31, 2024, and March 31, 2025.
• Nasdaq had previously granted exceptions for these filings until June 13, 2025, and July 14, 2025, respectively, but the Form 10-K was not filed by its extended deadline.
• An additional basis for delisting is the company's failure to comply with Nasdaq's minimum $2,500,000 stockholders' equity requirement, despite a previous claim of regaining compliance.
• Unless CIMG Inc. appeals the determination by July 7, 2025, trading of its common stock will be suspended from The Nasdaq Capital Market on July 9, 2025, and Nasdaq will initiate the delisting process.
• CIMG Inc. intends to file its Form 10-K before July 7, 2025, and appeal Nasdaq's delist determination by requesting a hearing to present its plan for regaining compliance with the applicable Nasdaq Listing Rules.

Sentiment

Score: 2

Explanation: The company faces imminent delisting from Nasdaq due to severe non-compliance with filing requirements and minimum stockholders' equity. While management intends to appeal and file, the current situation is critical and highly detrimental.

Positives

• CIMG Inc. intends to file its delinquent Form 10-K as soon as possible, and in any event before July 7, 2025.
• The company plans to appeal Nasdaq's delist determination and request a hearing to present a plan for regaining compliance.

Negatives

• Received a delist determination letter from Nasdaq.
• Failed to file Form 10-K for the year ended September 30, 2024, by the extended deadline of June 13, 2025.
• Failed to file Forms 10-Q for the periods ended December 31, 2024, and March 31, 2025.
• Did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing.
• Trading of common stock is set to be suspended from The Nasdaq Capital Market on July 9, 2025, if an appeal is not filed by July 7, 2025.
• Nasdaq will file a Form 25-NSE with the SEC to remove the company's securities from listing and registration if no appeal is made.

Risks

• Inability to satisfy continuing stock market listing standards and periodic reporting requirements.
• Potential delisting of common stock from Nasdaq, leading to reduced liquidity and investor interest.
• Inability to raise additional funding.
• Challenges in maintaining and growing the business.
• Variability of operating results.
• Difficulty in maintaining and enhancing the company's brand.
• Challenges in the development and introduction of new products and services.
• Issues with the successful integration of acquired companies, technologies, and assets.
• Impact of marketing and other business development initiatives.
• Competition within the digital health and sales development industry.
• Impact of general government regulation.
• Adverse economic conditions.
• Dependence on key personnel.
• Ability to attract, hire, and retain personnel with necessary technical skills and experience.
• Ability to protect intellectual property.

Future Outlook

CIMG Inc. intends to file its delinquent Form 10-K as soon as possible, specifically before July 7, 2025. The company also plans to appeal Nasdaq's delist determination and request a hearing before a Nasdaq Hearings Panel by July 7, 2025, to present its plan for regaining compliance with applicable Nasdaq Listing Rules.

Management Comments

• "The Company intends to file its Form 10-K for the fiscal year ended September 30, 2024 as soon as possible, and in any event before July 7, 2025."
• "In addition, the Company intends to appeal Nasdaqs delist determination and plans to request a hearing before a Nasdaq Hearings Panel to present its plan for regaining compliance with the applicable Nasdaq Listing Rules by 4:00 p.m. Eastern Time on July 7, 2025."

Industry Context

This announcement highlights a critical compliance issue for a company operating in the digital health and sales development sector. Timely and accurate financial reporting is a fundamental expectation for all publicly traded companies, regardless of industry. Failure to meet these basic listing requirements, as seen with CIMG Inc., can severely impact investor confidence and market access, underscoring the importance of robust internal controls and financial management in any industry.

Comparison to Industry Standards

• Timely filing of periodic reports (e.g., Form 10-K, Form 10-Q) is a universal and non-negotiable standard for all publicly traded companies on major exchanges like Nasdaq. CIMG Inc.'s failure to meet these deadlines is a significant deviation from standard corporate governance and financial reporting practices.
• Maintaining minimum stockholders' equity is a common listing requirement across exchanges globally, designed to ensure a certain level of financial stability. CIMG Inc.'s non-compliance with Nasdaq's $2,500,000 requirement indicates a financial position below typical exchange standards for continued listing.
• Comparable companies in the digital health and sales development sectors are expected to maintain strict compliance with these fundamental listing rules to ensure market access and investor trust. CIMG Inc.'s situation places it at a disadvantage compared to peers who consistently meet these regulatory obligations.

Stakeholder Impact

• Shareholders: Face significant risk of delisting, which would severely impact liquidity, potentially reduce share price, and make it harder to trade shares. The value of their investment is at high risk.
• Employees: Potential uncertainty regarding the company's future and stability if delisting occurs and business operations are impacted.
• Customers/Partners: May experience reduced confidence in CIMG Inc.'s long-term viability and stability, potentially affecting business relationships.
• Creditors: May view the company as a higher credit risk due to compliance issues and potential loss of public market access.

Next Steps

• CIMG Inc. to file its Form 10-K for the fiscal year ended September 30, 2024, as soon as possible, and in any event before July 7, 2025.
• CIMG Inc. to appeal Nasdaq's delist determination by July 7, 2025.
• CIMG Inc. to request a hearing before a Nasdaq Hearings Panel by July 7, 2025, to present its plan for regaining compliance.
• If no appeal, trading of CIMG Inc.'s common stock will be suspended from The Nasdaq Capital Market at the opening of business on July 9, 2025.
• If no appeal, Nasdaq will file a Form 25-NSE with the SEC to remove CIMG Inc.'s securities from listing and registration.

Key Dates

Recommendation

Keywords

CIMG Inc., IMG, Nasdaq, delisting, Form 10-K, Form 10-Q, financial reporting, compliance, stockholders equity, digital health, sales development, SEC filing, 8-K, corporate governance, risk management